Pubblicazioni
1: Martino G, Lo Cascio A, Bozzetti M, Martino S, Rumi G, Annese M, Bossa F,
Perri F, Papa A, Scaldaferri F, Napolitano D. Validation of the Italian-
Telemedicine Satisfaction Questionnaire in inflammatory bowel disease patients
in Italy. Minerva Gastroenterol (Torino). 2025 Sep;71(3):181-193. doi:
10.23736/S2724-5985.25.03957-9. PMID: 41190919.
2: Cocomazzi G, Villani A, Mencarelli G, Contu V, De Ruvo D, Virgili E, Marino
F, Baldini GM, Binda E, Parmegiani L, Ciampaglia W, Capone L, Perri F,
Cisternino A, Pazienza V, Panebianco C. Exploring the Intestinal Microbiota
Profile in Prostate Cancer Patients and Healthy Controls. Microorganisms. 2025
Sep 9;13(9):2105. doi: 10.3390/microorganisms13092105. PMID: 41011437; PMCID:
PMC12472378.
3: Tavano F, Palmieri O, Latiano M, Gioffreda D, Latiano T, Guerra M, Martino G,
Valvano MR, Bossa F, Perri F, Latiano A. Examination of the TPMT and NUDT15*3
Variants to Predict the Response to Thiopurines in an Italian Cohort of Patients
with Inflammatory Bowel Disease. Int J Mol Sci. 2025 Aug 14;26(16):7860. doi:
10.3390/ijms26167860. PMID: 40869181; PMCID: PMC12386799.
4: Terracciano F, Marra A, Bossa F, Bucci C, Dirodi A, Esposito F, Pastore MR,
Marseglia A, Valvano MR, Carparelli S, Ippolito AM, Nassisi V, Ferrara D, Perri
F. Transperineal Ultrasound Enhance Accuracy of Bowel Ultrasound in Assessing
Disease Activity in Pediatric Ulcerative Colitis Patients. Ultrasound Med Biol.
2025 Sep;51(9):1571-1579. doi: 10.1016/j.ultrasmedbio.2025.05.030. Epub 2025 Jun
28. PMID: 40582895.
5: Binda C, Facciorusso A, Fabbri S, Mutignani M, Tringali A, Di Mitri R,
Fugazza A, Sassatelli R, Gabbrielli A, Arcidiacono PG, Di Matteo FM, Coluccio C,
Di Marco M, Spada C, Fantin A, De Angelis C, Macchiarelli R, Perri F, Manno M,
Cugia L, Mussetto A, Repici A, Tarantino I, Anderloni A, Fabbri C; i‐EUS group.
Development and validation of a risk score for incomplete resection during
endoscopic papillectomy: PANETH score. Dig Endosc. 2025 Jul;37(7):749-757. doi:
10.1111/den.15005. Epub 2025 Mar 21. PMID: 40114644.
6: Cannarozzi AL, Biscaglia G, Parente P, Latiano TP, Gentile A, Ciardiello D,
Massimino L, Di Brina ALP, Guerra M, Tavano F, Ungaro F, Bossa F, Perri F,
Latiano A, Palmieri O. Artificial intelligence and whole slide imaging, a new
tool for the microsatellite instability prediction in colorectal cancer: Friend
or foe? Crit Rev Oncol Hematol. 2025 Jun;210:104694. doi:
10.1016/j.critrevonc.2025.104694. Epub 2025 Mar 8. PMID: 40064251.
7: Tavano F, Napoli A, Gioffreda D, Palmieri O, Latiano T, Tardio M, di Mola FF,
Grottola T, Büchler MW, Gentile M, Latiano A, Mazza T, Perri F. Could the
Microbial Profiling of Normal Pancreatic Tissue from Healthy Organ Donors
Contribute to Understanding the Intratumoral Microbiota Signature in Pancreatic
Ductal Adenocarcinoma? Microorganisms. 2025 Feb 19;13(2):452. doi:
10.3390/microorganisms13020452. PMID: 40005817; PMCID: PMC11858623.
8: Terracciano F, Marra A, Nassisi V, Lillo C, Bossa F, Carparelli S, Cocomazzi
F, Valvano MR, Losurdo G, Di Leo A, Perri F. Ultrasound Features of
<i>Helicobacter pylori</i>-Related Gastritis. Antibiotics (Basel). 2024 Dec
28;14(1):12. doi: 10.3390/antibiotics14010012. PMID: 39858298; PMCID:
PMC11763164.
9: Cocomazzi F, Gentile M, Carparelli S, Varano L, Perri F. Mucosal leak after
peroral endoscopic myotomy: what to do? Endoscopy. 2024 Dec;56(S 01):E955-E956.
doi: 10.1055/a-2446-6638. Epub 2024 Nov 8. PMID: 39515768; PMCID: PMC11548998.
10: Cannarozzi AL, Massimino L, Latiano A, Parigi TL, Giuliani F, Bossa F, Di
Brina AL, Ungaro F, Biscaglia G, Danese S, Perri F, Palmieri O. Artificial
intelligence: A new tool in the pathologist's armamentarium for the diagnosis of
IBD. Comput Struct Biotechnol J. 2024 Sep 11;23:3407-3417. doi:
10.1016/j.csbj.2024.09.003. PMID: 39345902; PMCID: PMC11437746.
11: Di Brina ALP, Palmieri O, Cannarozzi AL, Tavano F, Guerra M, Bossa F,
Gentile M, Merla A, Biscaglia G, Cuttitta A, Perri F, Latiano A. Focus on
Achalasia in the Omics Era. Int J Mol Sci. 2024 Sep 21;25(18):10148. doi:
10.3390/ijms251810148. PMID: 39337632; PMCID: PMC11431880.
12: Gálvez-Montosa F, Peduzzi G, Sanchez-Maldonado JM, Ter Horst R, Cabrera-
Serrano AJ, Gentiluomo M, Macauda A, Luque N, Ünal P, García-Verdejo FJ, Li Y,
López López JA, Stein A, Bueno-de-Mesquita HB, Arcidiacono PG, Zanette DL,
Kahlert C, Perri F, Soucek P, Talar-Wojnarowska R, Theodoropoulos GE, Izbicki
JR, Tamás H, Van Laarhoven H, Nappo G, Petrone MC, Lovecek M, Vermeulen RCH,
Adamonis K, Reyes-Zurita FJ, Holleczek B, Sumskiene J, Mohelníková-Duchoňová B,
Lawlor RT, Pezzilli R, Aoki MN, Pasquali C, Petrenkiene V, Basso D, Bunduc S,
Comandatore A, Brenner H, Ermini S, Vanella G, Goetz MR, Archibugi L, Lucchesi
M, Uzunoglu FG, Busch O, Milanetto AC, Puzzono M, Kupcinskas J, Morelli L,
Sperti C, Carrara S, Capurso G, van Eijck CHJ, Oliverius M, Roth S, Tavano F,
Kaaks R, Szentesi A, Vodickova L, Luchini C, Schöttker B, Landi S, Dohan O,
Tacelli M, Greenhalf W, Gazouli M, Neoptolemos JP, Cavestro GM, Boggi U, Latiano
A, Hegyi P, Ginocchi L, Netea MG, Sánchez-Rovira P, Canzian F, Campa D, Sainz J.
Polymorphisms within autophagy-related genes as susceptibility biomarkers for
pancreatic cancer: A meta-analysis of three large European cohorts and
functional characterization. Int J Cancer. 2025 Jan 15;156(2):339-352. doi:
10.1002/ijc.35196. Epub 2024 Sep 25. Erratum in: Int J Cancer. 2025 Sep
1;157(5):1022. doi: 10.1002/ijc.35510. PMID: 39319538; PMCID: PMC11578083.
13: Cannarozzi AL, Latiano A, Massimino L, Bossa F, Giuliani F, Riva M, Ungaro
F, Guerra M, Brina ALD, Biscaglia G, Tavano F, Carparelli S, Fiorino G, Danese
S, Perri F, Palmieri O. Inflammatory bowel disease genomics, transcriptomics,
proteomics and metagenomics meet artificial intelligence. United European
Gastroenterol J. 2024 Dec;12(10):1461-1480. doi: 10.1002/ueg2.12655. Epub 2024
Aug 31. PMID: 39215755; PMCID: PMC11652336.
14: Tavano F, Latiano A, Palmieri O, Gioffreda D, Latiano T, Gentile A, Tardio
M, Latiano TP, Gentile M, Terracciano F, Perri F. Duodenal Fluid Analysis as a
Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers.
Int J Mol Sci. 2024 Aug 2;25(15):8436. doi: 10.3390/ijms25158436. PMID:
39126005; PMCID: PMC11312909.
15: Giancola ML, Fontana A, Panebianco C, Mazzarelli A, Beccacece A, De Marco P,
Cocomazzi G, De Giuli C, Grassi G, Fontana C, Baldini GM, Contu V, Copetti M,
Perri F, Nicastri E, Pazienza V. Efficacy of a Multistrain Synbiotic Treatment
in Acute and Post-Acute COVID-19 Patients: A Double-Blind, Placebo-Controlled
Randomized Trial. Microorganisms. 2024 Jul 16;12(7):1443. doi:
10.3390/microorganisms12071443. PMID: 39065211; PMCID: PMC11279369.
16: Palmieri O, Bossa F, Castellana S, Latiano T, Carparelli S, Martino G,
Mangoni M, Corritore G, Nardella M, Guerra M, Biscaglia G, Perri F, Mazza T,
Latiano A. Deciphering Microbial Composition in Patients with Inflammatory Bowel
Disease: Implications for Therapeutic Response to Biologic Agents.
Microorganisms. 2024 Jun 21;12(7):1260. doi: 10.3390/microorganisms12071260.
PMID: 39065032; PMCID: PMC11278628.
17: Villani A, Fontana A, Panebianco C, Ferro C, Copetti M, Pavlovic R, Drago D,
Fiorentini C, Terracciano F, Bazzocchi F, Canistro G, Pisati F, Maiello E,
Latiano TP, Perri F, Pazienza V. A powerful machine learning approach to
identify interactions of differentially abundant gut microbial subsets in
patients with metastatic and non-metastatic pancreatic cancer. Gut Microbes.
2024 Jan-Dec;16(1):2375483. doi: 10.1080/19490976.2024.2375483. Epub 2024 Jul 7.
PMID: 38972056; PMCID: PMC11229760.
18: Cocomazzi F, Cubisino R, Gentile M, Perri F. Endoscopic Black Hole: A Case
of a Charcoal Tablet impacted in the Esophagus. J Gastrointestin Liver Dis. 2024
Jun 29;33(2):155. doi: 10.15403/jgld-5310. PMID: 38944850.
19: Corradi C, Lencioni G, Felici A, Rizzato C, Gentiluomo M, Ermini S,
Archibugi L, Mickevicius A, Lucchesi M, Malecka-Wojciesko E, Basso D,
Arcidiacono PG, Petrone MC, Carrara S, Götz M, Bunduc S, Holleczek B, Aoki MN,
Uzunoglu FG, Zanette DL, Mambrini A, Jamroziak K, Oliverius M, Lovecek M,
Cavestro GM, Milanetto AC, Peduzzi G, Duchonova BM, Izbicki JR, Zalinkevicius R,
Hlavac V, van Eijck CHJ, Brenner H, Vanella G, Vokacova K, Soucek P, Tavano F,
Perri F, Capurso G, Hussein T, Kiudelis M, Kupcinskas J, Busch OR, Morelli L,
Theodoropoulos GE, Testoni SGG, Adamonis K, Neoptolemos JP, Gazouli M, Pasquali
C, Kormos Z, Skalicky P, Pezzilli R, Sperti C, Kauffmann E, Büchler MW,
Schöttker B, Hegyi P, Capretti G, Lawlor RT, Canzian F, Campa D. Potential
association between PSCA rs2976395 functional variant and pancreatic cancer
risk. Int J Cancer. 2024 Oct 15;155(8):1432-1442. doi: 10.1002/ijc.35046. Epub
2024 Jun 26. PMID: 38924078.
20: Cocomazzi F, Carparelli S, Labarile N, Capogreco A, Gentile M, Maselli R,
Dhar J, Samanta J, Repici A, Hassan C, Perri F, Facciorusso A. Is there a best
choice of equipment for colorectal endoscopic submucosal dissection? Expert Rev
Med Devices. 2024 Jul;21(7):561-577. doi: 10.1080/17434440.2024.2364022. Epub
2024 Jun 4. PMID: 38829122.
21: Giaccherini M, Rende M, Gentiluomo M, Corradi C, Archibugi L, Ermini S,
Maiello E, Morelli L, van Eijck CHJ, Cavestro GM, Schneider M, Mickevicius A,
Adamonis K, Basso D, Hlavac V, Gioffreda D, Talar-Wojnarowska R, Schöttker B,
Lovecek M, Vanella G, Gazouli M, Uno M, Malecka-Wojciesko E, Vodicka P, Goetz M,
Bijlsma MF, Petrone MC, Bazzocchi F, Kiudelis M, Szentesi A, Carrara S, Nappo G,
Brenner H, Milanetto AC, Soucek P, Katzke V, Peduzzi G, Rizzato C, Pasquali C,
Chen X, Capurso G, Hackert T, Bueno-de-Mesquita B, Uzunoglu FG, Hegyi P,
Greenhalf W, Theodoropoulos GE, Sperti C, Perri F, Oliverius M, Mambrini A,
Tavano F, Farinella R, Arcidiacono PG, Lucchesi M, Bunduc S, Kupcinskas J, Di
Franco G, Stocker H, Neoptolemos JP, Bambi F, Jamroziak K, Testoni SGG, Aoki MN,
Mohelnikova-Duchonova B, Izbicki JR, Pezzilli R, Lawlor RT, Kauffmann EF, López
de Maturana E, Malats N, Canzian F, Campa D. A pleiotropy scan to discover new
susceptibility loci for pancreatic ductal adenocarcinoma. Mutagenesis. 2025 Mar
15;40(1):61-70. doi: 10.1093/mutage/geae012. PMID: 38606763.
22: Ünal P, Lu Y, Bueno-de-Mesquita B, van Eijck CHJ, Talar-Wojnarowska R,
Szentesi A, Gazouli M, Kreivenaite E, Tavano F, Małecka-Wojciesko E, Erőss B,
Oliverius M, Bunduc S, Nóbrega Aoki M, Vodickova L, Boggi U, Giaccherini M,
Kondrackiene J, Chammas R, Palmieri O, Theodoropoulos GE, Bijlsma MF, Basso D,
Mohelnikova-Duchonova B, Soucek P, Izbicki JR, Kiudelis V, Vanella G,
Arcidiacono PG, Włodarczyk B, Hackert T, Schöttker B, Uzunoglu FG, Bambi F,
Goetz M, Hlavac V, Brenner H, Perri F, Carrara S, Landi S, Hegyi P, Dijk F,
Maiello E, Capretti G, Testoni SGG, Petrone MC, Stocker H, Ermini S, Archibugi
L, Gentiluomo M, Cavestro GM, Pezzilli R, Di Franco G, Milanetto AC, Sperti C,
Neoptolemos JP, Morelli L, Vokacova K, Pasquali C, Lawlor RT, Bazzocchi F,
Kupcinskas J, Capurso G, Campa D, Canzian F. Polymorphisms in transcription
factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma
risk. Hum Genomics. 2024 Feb 2;18(1):12. doi: 10.1186/s40246-024-00576-x. PMID:
38308339; PMCID: PMC10837899.
23: Secondo D, Massaro D, Verrienti G, Perri F, Biscaglia G. Clostridioides
difficile Infection in the Neurorehabilitation Setting: Importance of a
Multidisciplinary Approach and Impact of the Fecal Microbiota Transplantation.
Cureus. 2023 Oct 6;15(10):e46574. doi: 10.7759/cureus.46574. PMID: 37937006;
PMCID: PMC10626206.
24: Donati Zeppa S, Natalucci V, Agostini D, Vallorani L, Amatori S, Sisti D,
Rocchi MBL, Pazienza V, Perri F, Villani A, Binda E, Panebianco C, Mencarelli G,
Ciuffreda L, Ferri Marini C, Annibalini G, Lucertini F, Bartolacci A, Imperio M,
Virgili E, Catalano V, Piccoli G, Stocchi V, Emili R, Barbieri E. Changes in gut
microbiota composition after 12 weeks of a home-based lifestyle intervention in
breast cancer survivors during the COVID-19 lockdown. Front Oncol. 2023 Sep
1;13:1225645. doi: 10.3389/fonc.2023.1225645. PMID: 37727203; PMCID:
PMC10505708.
25: Giaccherini M, Gori L, Gentiluomo M, Farinella R, Cervena K, Skieceviciene
J, Dijk F, Capurso G, Vezakis A, Archibugi L, Chammas R, Hussein T, Tavano F,
Hegyi P, Lovecek M, Izbicki JR, Brenner H, Mohelnikova-Duchonova B, Dell'Anna G,
Kupcinskas J, Ermini S, Aoki MN, Neoptolemos JP, Gazouli M, Pasquali C, Pezzilli
R, Talar-Wojnarowska R, Oliverius M, Al-Saeedi M, Lucchesi M, Furbetta N,
Carrara S, van Eijck CHJ, Maleckas A, Milanetto AC, Lawlor RT, Schöttker B,
Boggi U, Morelli L, Ginocchi L, Ponz de Leon Pisani R, Sperti C, Zerbi A,
Arcidiacono PG, Uzunoglu FG, Bunduc S, Holleczek B, Gioffreda D, Małecka-
Wojciesko E, Kiudelis M, Szentesi A, van Laarhoven HWM, Soucek P, Götz M, Erőss
B, Cavestro GM, Basso D, Perri F, Landi S, Canzian F, Campa D. A scan of all
coding region variants of the human genome, identifies 13q12.2-rs9579139 and
15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma.
Carcinogenesis. 2023 Dec 2;44(8-9):642-649. doi: 10.1093/carcin/bgad056. PMID:
37670727.
26: Piccardi M, Gentiluomo M, Bertoncini S, Pezzilli R, Erőss B, Bunduc S,
Uzunoglu FG, Talar-Wojnarowska R, Vanagas T, Sperti C, Oliverius M, Aoki MN,
Ermini S, Hussein T, Boggi U, Jamroziak K, Maiello E, Morelli L, Vodickova L, Di
Franco G, Landi S, Szentesi A, Lovecek M, Puzzono M, Tavano F, van Laarhoven
HWM, Zerbi A, Mohelnikova-Duchonova B, Stocker H, Costello E, Capurso G,
Ginocchi L, Lawlor RT, Vanella G, Bazzocchi F, Izbicki JR, Latiano A, Bueno-de-
Mesquita B, Ponz de Leon Pisani R, Schöttker B, Soucek P, Hegyi P, Gazouli M,
Hackert T, Kupcinskas J, Poskiene L, Tacelli M, Roth S, Carrara S, Perri F,
Hlavac V, Theodoropoulos GE, Busch OR, Mambrini A, van Eijck CHJ, Arcidiacono P,
Scarpa A, Pasquali C, Basso D, Lucchesi M, Milanetto AC, Neoptolemos JP,
Cavestro GM, Janciauskas D, Chen X, Chammas R, Goetz M, Brenner H, Archibugi L,
Dannemann M, Canzian F, Tofanelli S, Campa D. Exploring the Neandertal legacy of
pancreatic ductal adenocarcinoma risk in Eurasians. Biol Res. 2023 Aug
13;56(1):46. doi: 10.1186/s40659-023-00457-y. PMID: 37574541; PMCID:
PMC10424372.
27: Biscaglia G, Palmieri O, Biancofiore L, Parente P, Perri F. A metastatic
neuroendocrine carcinoma of ileal pouch in a woman with familial adenomatous
polyposis. J Gastrointestin Liver Dis. 2023 Jun 22;32(2):263-265. doi:
10.15403/jgld-4839. PMID: 37345603.
28: Palmieri O, Castellana S, Latiano A, Latiano T, Gentile A, Panza A, Nardella
M, Ciardiello D, Latiano TP, Corritore G, Mazza T, Perri F, Biscaglia G. Mucosal
Microbiota from Colorectal Cancer, Adenoma and Normal Epithelium Reveals the
Imprint of <i>Fusobacterium nucleatum</i> in Cancerogenesis. Microorganisms.
2023 Apr 28;11(5):1147. doi: 10.3390/microorganisms11051147. PMID: 37317121;
PMCID: PMC10222013.
29: Campa D, Gentiluomo M, Stein A, Aoki MN, Oliverius M, Vodičková L, Jamroziak
K, Theodoropoulos G, Pasquali C, Greenhalf W, Arcidiacono PG, Uzunoglu F,
Pezzilli R, Luchini C, Puzzono M, Loos M, Giaccherini M, Katzke V, Mambrini A,
Kiudeliene E, Federico KE, Johansen J, Hussein T, Mohelnikova-Duchonova B, van
Eijck CHJ, Brenner H, Farinella R, Pérez JS, Lovecek M, Büchler MW, Hlavac V,
Izbicki JR, Hackert T, Chammas R, Zerbi A, Lawlor R, Felici A, Götz M, Capurso
G, Ginocchi L, Gazouli M, Kupcinskas J, Cavestro GM, Vodicka P, Moz S,
Neoptolemos JP, Kunovsky L, Bojesen SE, Carrara S, Gioffreda D, Morkunas E,
Abian O, Bunduc S, Basso D, Boggi U, Wlodarczyk B, Szentesi A, Vanella G, Chen
I, Bijlsma MF, Kiudelis V, Landi S, Schöttker B, Corradi C, Giese N, Kaaks R,
Peduzzi G, Hegyi P, Morelli L, Furbetta N, Soucek P, Latiano A, Talar-
Wojnarowska R, Lindgaard SC, Dijk F, Milanetto AC, Tavano F, Cervena K, Erőss B,
Testoni SG, Verhagen-Oldenampsen JHE, Małecka-Wojciesko E, Costello E, Salvia R,
Maiello E, Ermini S, Sperti C, Holleczek B, Perri F, Skieceviciene J, Archibugi
L, Lucchesi M, Rizzato C, Canzian F. The PANcreatic Disease ReseArch (PANDoRA)
consortium: Ten years' experience of association studies to understand the
genetic architecture of pancreatic cancer. Crit Rev Oncol Hematol. 2023
Jun;186:104020. doi: 10.1016/j.critrevonc.2023.104020. Epub 2023 May 8. PMID:
37164172.
30: Corradi C, Lencioni G, Gentiluomo M, Felici A, Latiano A, Kiudelis G, van
Eijck CHJ, Marta K, Lawlor RT, Tavano F, Boggi U, Dijk F, Cavestro GM, Vermeulen
RCH, Hackert T, Petrone MC, Uzunoğlu FG, Archibugi L, Izbicki JR, Morelli L,
Zerbi A, Landi S, Stocker H, Talar-Wojnarowska R, Di Franco G, Hegyi P, Sperti
C, Carrara S, Capurso G, Gazouli M, Brenner H, Bunduc S, Busch O, Perri F,
Oliverius M, Hegyi PJ, Goetz M, Scognamiglio P, Mambrini A, Arcidiacono PG,
Kreivenaite E, Kupcinskas J, Hussein T, Ermini S, Milanetto AC, Vodicka P,
Kiudelis V, Hlaváč V, Soucek P, Theodoropoulos GE, Basso D, Neoptolemos JP,
Nóbrega Aoki M, Pezzilli R, Pasquali C, Chammas R, Testoni SGG, Mohelnikova-
Duchonova B, Lucchesi M, Rizzato C, Canzian F, Campa D. Polymorphic variants
involved in methylation regulation: a strategy to discover risk loci for
pancreatic ductal adenocarcinoma. J Med Genet. 2023 Oct;60(10):980-986. doi:
10.1136/jmg-2022-108910. Epub 2023 May 2. PMID: 37130759.
31: Panebianco C, Pisati F, Villani A, Andolfo A, Ulaszewska M, Bellini E, Ferro
C, Lombardi R, Orsenigo F, Latiano TP, Belmonte B, Tripodo C, Perri F, Pazienza
V. Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type
and KRAS<sup>G12D</sup> mutated pancreatic cancer in vivo model. Cell Death
Discov. 2023 Apr 5;9(1):116. doi: 10.1038/s41420-023-01397-y. PMID: 37019893;
PMCID: PMC10076501.
32: Nodari Y, Gentiluomo M, Mohelnikova-Duchonova B, Kreivenaite E, Milanetto
AC, Skieceviciene J, Landi S, Lawlor RT, Petrone MC, Arcidiacono PG, Lovecek M,
Gazouli M, Bijlsma MF, Morelli L, Kiudelis V, Tacelli M, Zanette DL, Soucek P,
Uzunoglu F, Kaaks R, Izbicki J, Boggi U, Pezzilli R, Mambrini A, Pasquali C, van
Laarhoven HW, Katzke V, Cavestro GM, Sperti C, Loos M, Latiano A, Erőss B,
Oliverius M, Johnson T, Basso D, Neoptolemos JP, Aoki MN, Greenhalf W, Vodicka
P, Archibugi L, Vanella G, Lucchesi M, Talar-Wojnarowska R, Jamroziak K, Saeedi
MA, van Eijck CHJ, Kupcinskas J, Hussein T, Puzzono M, Bunduc S, Götz M, Carrara
S, Szentesi A, Tavano F, Moz S, Hegyi P, Luchini C, Capurso G, Perri F, Ermini
S, Theodoropoulos G, Capretti G, Palmieri O, Ginocchi L, Furbetta N, Canzian F,
Campa D. Genetic and non-genetic risk factors for early-onset pancreatic cancer.
Dig Liver Dis. 2023 Oct;55(10):1417-1425. doi: 10.1016/j.dld.2023.02.023. Epub
2023 Mar 25. PMID: 36973108.
33: Manna L, Rizzi E, Bafile E, Cappelleri A, Ruscica M, Macchi C, Podaliri
Vulpiani M, Salini R, Rossi E, Panebianco C, Perri F, Pazienza V, Federici F.
<i>Lentilactobacillus kefiri</i> SGL 13 and <i>Andrographis paniculata</i>
alleviate dextran sulfate sodium induced colitis in mice. Front Nutr. 2023 Feb
13;10:1072334. doi: 10.3389/fnut.2023.1072334. PMID: 36860688; PMCID:
PMC9968723.
34: Massimino L, Palmieri O, Facoetti A, Fuggetta D, Spanò S, Lamparelli LA,
D'Alessio S, Cagliani S, Furfaro F, D'Amico F, Zilli A, Fiorino G, Parigi TL,
Noviello D, Latiano A, Bossa F, Latiano T, Pirola A, Mologni L, Piazza RG,
Abbati D, Perri F, Bonini C, Peyrin-Biroulet L, Malesci A, Jairath V, Danese S,
Ungaro F. Gut virome-colonising <i>Orthohepadnavirus</i> genus is associated
with ulcerative colitis pathogenesis and induces intestinal inflammation <i>in
vivo</i>. Gut. 2023 Oct;72(10):1838-1847. doi: 10.1136/gutjnl-2022-328375. Epub
2023 Feb 14. PMID: 36788014; PMCID: PMC10511988.
35: Panebianco C, Villani A, Potenza A, Favaro E, Finocchiaro C, Perri F,
Pazienza V. Targeting Gut Microbiota in Cancer Cachexia: Towards New Treatment
Options. Int J Mol Sci. 2023 Jan 17;24(3):1849. doi: 10.3390/ijms24031849. PMID:
36768173; PMCID: PMC9916111.
36: Tavano F, Gioffreda D, Fontana A, Palmieri O, Gentile A, Latiano T, Latiano
A, Latiano TP, Scaramuzzi M, Maiello E, Bazzocchi F, Perri F. Evaluation of
inherited germline mutations in cancer susceptibility genes among pancreatic
cancer patients: a single-center study. Mol Med. 2023 Jan 30;29(1):14. doi:
10.1186/s10020-023-00600-1. PMID: 36717774; PMCID: PMC9885574.
37: Micale L, Fusco C, Nardella G, Palmieri O, Latiano T, Gioffreda D, Tavano F,
Panza A, Merla A, Biscaglia G, Gentile M, Cuttitta A, Castori M, Perri F,
Latiano A. Downexpression of miR-200c-3p Contributes to Achalasia Disease by
Targeting the <i>PRKG1</i> Gene. Int J Mol Sci. 2022 Dec 30;24(1):668. doi:
10.3390/ijms24010668. PMID: 36614110; PMCID: PMC9820813.
38: Mazzarelli A, Giancola ML, Fontana A, Piselli P, Binda E, Trivieri N,
Mencarelli G, Marchioni L, Vulcano A, De Giuli C, Panebianco C, Villani A,
Copetti M, Perri F, Fontana C, Nicastri E, Pazienza V. Gut microbiota
composition in COVID-19 hospitalized patients with mild or severe symptoms.
Front Microbiol. 2022 Dec 6;13:1049215. doi: 10.3389/fmicb.2022.1049215. PMID:
36560946; PMCID: PMC9763305.
39: Giaccherini M, Farinella R, Gentiluomo M, Mohelnikova-Duchonova B, Kauffmann
EF, Palmeri M, Uzunoglu F, Soucek P, Petrauskas D, Cavestro GM, Zykus R, Carrara
S, Pezzilli R, Puzzono M, Szentesi A, Neoptolemos J, Archibugi L, Palmieri O,
Milanetto AC, Capurso G, van Eijck CHJ, Stocker H, Lawlor RT, Vodicka P, Lovecek
M, Izbicki JR, Perri F, Kupcinskaite-Noreikiene R, Götz M, Kupcinskas J, Hussein
T, Hegyi P, Busch OR, Hackert T, Mambrini A, Brenner H, Lucchesi M, Basso D,
Tavano F, Schöttker B, Vanella G, Bunduc S, Petrányi Á, Landi S, Morelli L,
Canzian F, Campa D. Association between a polymorphic variant in the
CDKN2B-AS1/ANRIL gene and pancreatic cancer risk. Int J Cancer. 2023 Jul
15;153(2):373-379. doi: 10.1002/ijc.34383. Epub 2022 Dec 14. PMID: 36451333.
40: Bossa F, Valvano MR, Guerra M, Lopetuso LR, Carparelli S,
Mignini I, Cocomazzi F, Napolitano D, Costantino A, Caprioli F, Gasbarrini A,
Perri F, Papa A. Evaluation of factors associated with trust in telemedicine in
patients with inflammatory bowel disease during COVID-19 pandemic: a multicenter
cross-sectional survey. Eur Rev Med Pharmacol Sci. 2022 Oct;26(19):7277-7284.
doi: 10.26355/eurrev_202210_29921. PMID: 36263539.
41: Palmieri O, Castellana S, Bevilacqua A, Latiano A, Latiano T, Panza A,
Fontana R, Ippolito AM, Biscaglia G, Gentile A, Gioffreda D, Decina I, Tricarico
M, Sinigaglia M, Corbo MR, Mazza T, Perri F, Lamacchia C. Adherence to Gluten-
Free Diet Restores Alpha Diversity in Celiac People but the Microbiome
Composition Is Different to Healthy People. Nutrients. 2022 Jun 14;14(12):2452.
doi: 10.3390/nu14122452. PMID: 35745182; PMCID: PMC9228530.
42: Panebianco C, Villani A, Pisati F, Orsenigo F, Ulaszewska M, Latiano TP,
Potenza A, Andolfo A, Terracciano F, Tripodo C, Perri F, Pazienza V. Butyrate, a
postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine
response in in vitro and in vivo models. Biomed Pharmacother. 2022
Jul;151:113163. doi: 10.1016/j.biopha.2022.113163. Epub 2022 May 24. PMID:
35617803.
43: Biscaglia G, Cocomazzi F, Gentile M, Loconte I, Mileti A, Paolillo R, Marra
A, Castellana S, Mazza T, Di Leo A, Perri F. Real-time, computer-aided,
detection-assisted colonoscopy eliminates differences in adenoma detection rate
between trainee and experienced endoscopists. Endosc Int Open. 2022 May
13;10(5):E616-E621. doi: 10.1055/a-1783-9678. PMID: 35571479; PMCID: PMC9106428.
44: Gentiluomo M, Capurso G, Morelli L, Ermini S, Pasquali C, Latiano A, Tavano
F, Greenhalf W, Milanetto AC, Landi S, Roth S, Malecka-Wojciesko E, Costello E,
Jamroziak K, Perri F, Boggi U, Basso D, Farinati F, Kaaks R, Vanella G, Gais
Zurcher AJ, Archibugi L, Lawlor RT, Canzian F, Campa D. Genetically Determined
Telomere Length Is Associated with Pancreatic Neuroendocrine Neoplasms Onset.
Neuroendocrinology. 2022;112(12):1168-1176. doi: 10.1159/000524659. Epub 2022
Apr 26. PMID: 35472852.
45: Villani A, Fontana A, Barone S, de Stefani S, Primiterra M, Copetti M,
Panebianco C, Parri C, Sciannamè N, Quitadamo PA, Tiezzi A, Santana L, Maglione
A, D'Amato F, Perri F, Palini S, Pazienza V. Identifying Predictive Bacterial
Markers from Cervical Swab Microbiota on Pregnancy Outcome in Woman Undergoing
Assisted Reproductive Technologies. J Clin Med. 2022 Jan 28;11(3):680. doi:
10.3390/jcm11030680. PMID: 35160131; PMCID: PMC8836651.
46: Panebianco C, Pisati F, Ulaszewska M, Andolfo A, Villani A, Federici F,
Laura M, Rizzi E, Potenza A, Latiano TP, Perri F, Tripodo C, Pazienza V. Tuning
gut microbiota through a probiotic blend in gemcitabine-treated pancreatic
cancer xenografted mice. Clin Transl Med. 2021 Nov;11(11):e580. doi:
10.1002/ctm2.580. PMID: 34841697; PMCID: PMC8567057.
47: Panebianco C, Ciardiello D, Villani A, Maiorano BA, Latiano TP, Maiello E,
Perri F, Pazienza V. Insights into the role of gut and intratumor microbiota in
pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic
and therapeutic perspective. Semin Cancer Biol. 2022 Nov;86(Pt 3):997-1007. doi:
10.1016/j.semcancer.2021.11.007. Epub 2021 Nov 25. PMID: 34838957.
48: Palmieri O, Castellana S, Biscaglia G, Panza A, Latiano A, Fontana R, Guerra
M, Corritore G, Latiano T, Martino G, Mazza T, Andriulli A, Perri F, Bossa F.
Microbiome Analysis of Mucosal Ileoanal Pouch in Ulcerative Colitis Patients
Revealed Impairment of the Pouches Immunometabolites. Cells. 2021 Nov
19;10(11):3243. doi: 10.3390/cells10113243. PMID: 34831464; PMCID: PMC8624401.
49: Peduzzi G, Gentiluomo M, Tavano F, Arcidiacono PG, Ermini S, Vodicka P,
Boggi U, Cavestro GM, Capurso G, Morelli L, Milanetto AC, Pezzilli R, Lawlor RT,
Carrara S, Lovecek M, Souček P, Guo F, Hackert T, Uzunoğlu FG, Gazouli M,
Párniczky A, Kupcinskas J, Bijlsma MF, Bueno-de-Mesquita B, Vermeulen R, van
Eijck CHJ, Jamroziak K, Talar-Wojnarowska R, Greenhalf W, Gioffreda D, Petrone
MC, Landi S, Archibugi L, Puzzono M, Funel N, Sperti C, Piredda ML, Mohelnikova-
Duchonova B, Lu Y, Hlaváč V, Gao X, Schneider M, Izbicki JR, Theodoropoulos G,
Bunduc S, Kreivenaite E, Busch OR, Małecka-Panas E, Costello E, Perri F, Testoni
SGG, Vanella G, Pasquali C, Oliverius M, Brenner H, Loos M, Götz M, Georgiou K,
Erőss B, Maiello E, Szentesi A, Bazzocchi F, Basso D, Neoptolemos JP, Hegyi P,
Kiudelis V, Canzian F, Campa D. Genetic Polymorphisms Involved in Mitochondrial
Metabolism and Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2021
Dec;30(12):2342-2345. doi: 10.1158/1055-9965.EPI-21-0353. Epub 2021 Sep 15.
PMID: 34526302.
50: Biscaglia G, Latiano A, Castellana S, Fontana R, Gentile A, Latiano T,
Corritore G, Panza A, Nardella M, Martino G, Bossa F, Perri F, Mazza T,
Andriulli A, Palmieri O. Germline Alterations in Patients With IBD-associated
Colorectal Cancer. Inflamm Bowel Dis. 2022 Mar 2;28(3):447-454. doi:
10.1093/ibd/izab195. PMID: 34347074.
51: Cocomazzi F, Perri F, Parente P, Gentile M. A diminutive polyp with
synchronous liver metastasis: Luck or skill? Dig Liver Dis. 2022
Jul;54(7):990-991. doi: 10.1016/j.dld.2021.05.019. Epub 2021 Jun 17. PMID:
34147348.
52: Cocomazzi F, Carparelli S, Cubisino R, Giuliani AP, Bossa F, Biscaglia G,
Parente P, Andriulli A, Perri F, Gentile M. Inverted colonic diverticulum (ICD):
report of two cases and literature review of a not that unusual endoscopic
challenge. Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101711. doi:
10.1016/j.clinre.2021.101711. Epub 2021 Apr 27. PMID: 33930589.
53: Panebianco C, Trivieri N, Villani A, Terracciano F, Latiano TP, Potenza A,
Perri F, Binda E, Pazienza V. Improving Gemcitabine Sensitivity in Pancreatic
Cancer Cells by Restoring miRNA-217 Levels. Biomolecules. 2021 Apr 26;11(5):639.
doi: 10.3390/biom11050639. PMID: 33925948; PMCID: PMC8146031.
54: Piazzolla M, Marmo R, Terracciano F, Perri F, Biscaglia G. Asymptomatic
retention of fragmented small bowel capsule endoscopy retrieved by retrograde
double-balloon enteroscopy in Crohn's disease. Eur J Gastroenterol Hepatol. 2021
Dec 1;33(1S Suppl 1):e1082-e1083. doi: 10.1097/MEG.0000000000002128. PMID:
33905218.
55: Carparelli S, Pastore MR, Valvano MR, Marseglia A, Latiano A, Palmieri O,
Guerra M, Martino G, Perri F, Bossa F. Worse impact of second wave COVID-19
pandemic in adults but not in children with inflammatory bowel disease: an
Italian single tertiary center experience. Eur Rev Med Pharmacol Sci. 2021
Mar;25(6):2744-2747. doi: 10.26355/eurrev_202103_25437. PMID: 33829460.
56: Cocomazzi F, Gentile M, Perri F, Bossa F, Merla A, Ippolito A, Cubisino R,
Carparelli S, Marra A, Mileti A, Piazzolla M, Paolillo R, Copetti M, Parente P,
Graziano P, Di Leo A, Andriulli A. Correction to: Accuracy and inter-observer
agreement of the nice and kudo classifications of superficial colonic lesions: a
comparative study. Int J Colorectal Dis. 2021 Jul;36(7):1569. doi:
10.1007/s00384-021-03905-x. Erratum for: Int J Colorectal Dis. 2021
Jul;36(7):1561-1568. doi: 10.1007/s00384-021-03897-8. PMID: 33712905.
57: Cocomazzi F, Gentile M, Perri F, Merla A, Bossa F, Piazzolla M, Ippolito A,
Terracciano F, Giuliani AP, Cubisino R, Marra A, Carparelli S, Mileti A,
Paolillo R, Fontana A, Copetti M, Di Leo A, Andriulli A. Interobserver agreement
of the Paris and simplified classifications of superficial colonic lesions: a
Western study. Endosc Int Open. 2021 Mar;9(3):E388-E394. doi:
10.1055/a-1352-3437. Epub 2021 Feb 19. PMID: 33655038; PMCID: PMC7895665.
58: Cocomazzi F, Gentile M, Perri F, Bossa F, Merla A, Ippolito A, Cubisino R,
Carparelli S, Marra A, Mileti A, Piazzolla M, Paolillo R, Copetti M, Parente P,
Graziano P, Di Leo A, Andriulli A. Accuracy and inter-observer agreement of the
nice and kudo classifications of superficial colonic lesions: a comparative
study. Int J Colorectal Dis. 2021 Jul;36(7):1561-1568. doi:
10.1007/s00384-021-03897-8. Epub 2021 Mar 1. Erratum in: Int J Colorectal Dis.
2021 Jul;36(7):1569. doi: 10.1007/s00384-021-03905-x. PMID: 33649902.
59: Bossa F, Carparelli S, Latiano A, Palmieri O, Tavano F, Panza A, Pastore M,
Marseglia A, D'Altilia M, Latiano T, Corritore G, Martino G, Nardella M, Guerra
M, Terracciano F, Sacco M, Perri F, Andriulli A. Impact of the COVID-19 outbreak
and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory
bowel disease treated with biologic drugs. Dig Liver Dis. 2021
Mar;53(3):277-282. doi: 10.1016/j.dld.2020.12.120. Epub 2021 Jan 6. PMID:
33423942; PMCID: PMC7834247.
60: Trivieri N, Panebianco C, Villani A, Pracella R, Latiano TP, Perri F, Binda
E, Pazienza V. High Levels of Prebiotic Resistant Starch in Diet Modulate a
Specific Pattern of miRNAs Expression Profile Associated to a Better Overall
Survival in Pancreatic Cancer. Biomolecules. 2020 Dec 29;11(1):26. doi:
10.3390/biom11010026. PMID: 33383727; PMCID: PMC7824309.
61: Panza A, Castellana S, Biscaglia G, Piepoli A, Parca L, Gentile A, Latiano
A, Mazza T, Perri F, Andriulli A, Palmieri O. Transcriptome and Gene Fusion
Analysis of Synchronous Lesions Reveals lncMRPS31P5 as a Novel Transcript
Involved in Colorectal Cancer. Int J Mol Sci. 2020 Sep 27;21(19):7120. doi:
10.3390/ijms21197120. PMID: 32992457; PMCID: PMC7582694.
62: Losurdo G, Leandro G, Ierardi E, Perri F, Barone M, Principi M, Leo AD.
Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial
Overgrowth: A Systematic Review With Meta-analysis. J Neurogastroenterol Motil.
2020 Jan 30;26(1):16-28. doi: 10.5056/jnm19113. PMID: 31743632; PMCID:
PMC6955189.
63: Armuzzi A, Fiorino G, Variola A, Manetti N, Fries W, Orlando A, Maconi G,
Bossa F, Cappello M, Biancone L, Cantoro L, Costa F, D'Incà R, Lionetti P,
Principi M, Castiglione F, Annunziata ML, Di Sabatino A, Di Girolamo M, Terpin
MM, Cortelezzi CC, Saibeni S, Amato A, Ardizzone S, Guidi L, Danese S, Massella
A, Ventra A, Rizzuto G, Massari A, Perri F, Annese V; PROSIT Investigators. The
PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the
Effectiveness and Safety Across Italy. Inflamm Bowel Dis. 2019 Feb
21;25(3):568-579. doi: 10.1093/ibd/izy264. PMID: 30137352.
64: Terracciano F, Scalisi G, Bossa F, Scimeca D, Biscaglia G, Mangiacotti M,
Valvano MR, Perri F, Simeone A, Andriulli A. Transperineal ultrasonography:
First level exam in IBD patients with perianal disease. Dig Liver Dis. 2016
Aug;48(8):874-9. doi: 10.1016/j.dld.2016.03.027. Epub 2016 Apr 26. PMID:
27185514.
65: Bossa F, Perri F, Niro G, Parente P, Graziano P, Andriulli A. Letter:
cytomegalovirus colitis in a patient treated with ipilimumab for metastatic
melanoma. Aliment Pharmacol Ther. 2016 Jan;43(1):174-5. doi: 10.1111/apt.13451.
PMID: 26638939.
66: Zullo A, Esposito G, Ridola L, Hassan C, Lahner E, Perri F, Bianco MA, De
Francesco V, Buscarini E, Di Giulio E, Annibale B; AIGO-SIED study group; AIGO-
SIED study group. Prevalence of lesions detected at upper endoscopy: an Italian
survey. Eur J Intern Med. 2014 Oct;25(8):772-6. doi: 10.1016/j.ejim.2014.08.010.
Epub 2014 Sep 20. PMID: 25245606.
67: Lahner E, Zullo A, Hassan C, Perri F, Dinis-Ribeiro M, Esposito G, Di Giulio
E, Buscarini E, Bianco MA, De Boni M; MAG-Study Group; Annibale B. Detection of
gastric precancerous conditions in daily clinical practice: a nationwide survey.
Helicobacter. 2014 Dec;19(6):417-24. doi: 10.1111/hel.12149. Epub 2014 Sep 18.
Erratum in: Helicobacter. 2016 Feb;21(1):82. doi: 10.1111/hel.12239. PMID:
25231208.
68: Petrone MC, Terracciano F, Perri F, Carrara S, Cavestro GM, Mariani A,
Testoni PA, Arcidiacono PG. Pancreatic abnormalities detected by endoscopic
ultrasound (EUS) in patients without clinical signs of pancreatic disease: any
difference between standard and Rosemont classification scoring? Pancreatology.
2014 May-Jun;14(3):227-30. doi: 10.1016/j.pan.2014.03.002. Epub 2014 Mar 28.
PMID: 24854620.
69: Festa V, Andriulli A, Valvano MR, Uomo G, Perri F, Andriulli N, Corrao S,
Koch M. Neoadjuvant chemo-radiotherapy for patients with borderline resectable
pancreatic cancer: a meta-analytical evaluation of prospective studies. JOP.
2013 Nov 10;14(6):618-25. doi: 10.6092/1590-8577/1724. PMID: 24216547.
70: Perri F. EUS-guided FNA of solid pancreatic masses with or without on-site
cytological evaluation: more sample adequacy with less needle passes? Am J
Gastroenterol. 2012 Mar;107(3):490. doi: 10.1038/ajg.2011.452. PMID: 22388036.
71: Perri F, Gentile M, Scimeca D, Terracciano F, Merla A, Spirito F, Andriulli
A. Closure of a gastrocutaneous fistula by a tulip-bundle technique. Endoscopy.
2011;43 Suppl 2 UCTN:E419. doi: 10.1055/s-0030-1256957. Epub 2012 Jan 24. PMID:
22275032.
72: Perri F, Terracciano F, Gentile M, Merla A, Scimeca D, Andriulli A.
Endoscopic removal of gallstone impacted in the rectum. Endoscopy. 2011;43 Suppl
2 UCTN:E408-9. doi: 10.1055/s-0030-1256949. Epub 2012 Jan 24. PMID: 22275026.
73: Rocco A, de Nucci G, Valente G, Compare D, D'Arienzo A, Cimino L, Perri F,
Nardone G. 13C-aminopyrine breath test accurately predicts long-term outcome of
chronic hepatitis C. J Hepatol. 2012 Apr;56(4):782-7. doi:
10.1016/j.jhep.2011.10.015. Epub 2011 Dec 13. PMID: 22173159.
74: Bisceglia M, Perri F, Tucci A, Tardio M, Panniello G, Vita G, Pasquinelli G.
Primary malignant melanoma of the esophagus: a clinicopathologic study of a case
with comprehensive literature review. Adv Anat Pathol. 2011 May;18(3):235-52.
doi: 10.1097/PAP.0b013e318216b99b. PMID: 21490441.
75: Perri F, Terracciano F, Gentile M, Merla A, Scimeca D, Zullo A. Role of
interleukin polymorphisms in gastric cancer: "Pros and cons". World J
Gastrointest Oncol. 2010 Jun 15;2(6):265-71. doi: 10.4251/wjgo.v2.i6.265. PMID:
21160639; PMCID: PMC2999189.
76: Zullo A, Hassan C, Cristofari F, Perri F, Morini S. Gastric low-grade
mucosal-associated lymphoid tissue-lymphoma: Helicobacter pylori and beyond.
World J Gastrointest Oncol. 2010 Apr 15;2(4):181-6. doi: 10.4251/wjgo.v2.i4.181.
PMID: 21160595; PMCID: PMC2998825.
77: Iacobellis A, Perri F, Valvano MR, Caruso N, Niro GA, Andriulli A. Long-term
outcome after antiviral therapy of patients with hepatitis C virus infection and
decompensated cirrhosis. Clin Gastroenterol Hepatol. 2011 Mar;9(3):249-53. doi:
10.1016/j.cgh.2010.10.036. Epub 2010 Nov 17. PMID: 21092761.
78: Petrone MC, Arcidiacono PG, Perri F, Carrara S, Boemo C, Testoni PA. Chronic
pancreatitis-like changes detected by endoscopic ultrasound in subjects without
signs of pancreatic disease: do these indicate age-related changes, effects of
xenobiotics, or early chronic pancreatitis? Pancreatology. 2010;10(5):597-602.
doi: 10.1159/000314599. Epub 2010 Oct 29. PMID: 20980777.
79: Tack GJ, Wondergem MJ, Al-Toma A, Verbeek WH, Schmittel A, Machado MV, Perri
F, Ossenkoppele GJ, Huijgens PC, Schreurs MW, Mulder CJ, Visser OJ. Auto-SCT in
refractory celiac disease type II patients unresponsive to cladribine therapy.
Bone Marrow Transplant. 2011 Jun;46(6):840-6. doi: 10.1038/bmt.2010.199. Epub
2010 Sep 6. PMID: 20818442.
80: Perri F, Iacobellis A, Gentile M, Tumino E, Andriulli A. The intelligent,
painless, "germ-free" colonoscopy: A Columbus' egg for increasing population
adherence to colorectal cancer screening? Dig Liver Dis. 2010 Dec;42(12):839-43.
doi: 10.1016/j.dld.2010.06.007. Epub 2010 Aug 4. PMID: 20688586.
81: Perri F, Bellini M, Portincasa P, Parodi A, Bonazzi P, Marzio L, Galeazzi F,
Usai P, Citrino A, Usai-Satta P. (13)C-octanoic acid breath test (OBT) with a
new test meal (EXPIROGer): Toward standardization for testing gastric emptying
of solids. Dig Liver Dis. 2010 Aug;42(8):549-53. doi: 10.1016/j.dld.2010.01.001.
Epub 2010 Jan 29. PMID: 20116352.
82: Mezzi G, Arcidiacono PG, Carrara S, Perri F, Petrone MC, De Cobelli F,
Gusmini S, Staudacher C, Del Maschio A, Testoni PA. Endoscopic ultrasound and
magnetic resonance imaging for re-staging rectal cancer after radiotherapy.
World J Gastroenterol. 2009 Nov 28;15(44):5563-7. doi: 10.3748/wjg.15.5563.
PMID: 19938195; PMCID: PMC2785059.
83: Gasbarrini A, Corazza GR, Gasbarrini G, Montalto M, Di Stefano M, Basilisco
G, Parodi A, Usai-Satta P, Vernia P, Anania C, Astegiano M, Barbara G, Benini L,
Bonazzi P, Capurso G, Certo M, Colecchia A, Cuoco L, Di Sario A, Festi D,
Lauritano C, Miceli E, Nardone G, Perri F, Portincasa P, Risicato R, Sorge M,
Tursi A; 1st Rome H2-Breath Testing Consensus Conference Working Group.
Methodology and indications of H2-breath testing in gastrointestinal diseases:
the Rome Consensus Conference. Aliment Pharmacol Ther. 2009 Mar 30;29 Suppl
1:1-49. doi: 10.1111/j.1365-2036.2009.03951.x. Erratum in: Aliment Pharmacol
Ther. 2010 Jan;31(1):166. Satta PU [corrected to Usai-Satta P]. PMID: 19344474.
84: Piepoli A, Cotugno R, Merla G, Gentile A, Augello B, Quitadamo M, Merla A,
Panza A, Carella M, Maglietta R, D'Addabbo A, Ancona N, Fusilli S, Perri F,
Andriulli A. Promoter methylation correlates with reduced NDRG2 expression in
advanced colon tumour. BMC Med Genomics. 2009 Mar 3;2:11. doi:
10.1186/1755-8794-2-11. PMID: 19257893; PMCID: PMC2660908.
85: Andriulli A, Loperfido S, Focareta R, Leo P, Fornari F, Garripoli A, Tonti
P, Peyre S, Spadaccini A, Marmo R, Merla A, Caroli A, Forte GB, Belmonte A,
Aragona G, Imperiali G, Forte F, Monica F, Caruso N, Perri F. High- versus low-
dose proton pump inhibitors after endoscopic hemostasis in patients with peptic
ulcer bleeding: a multicentre, randomized study. Am J Gastroenterol. 2008
Dec;103(12):3011-8. doi: 10.1111/j.1572-0241.2008.02149.x. PMID: 19086953.
86: Andriulli A, Grossi E, Buscema M, Pilotto A, Festa V, Perri F. Artificial
neural networks can classify uninvestigated patients with dyspepsia. Eur J
Gastroenterol Hepatol. 2007 Dec;19(12):1055-8. doi:
10.1097/MEG.0b013e3282f198b2. PMID: 17998828.
87: Maglietta R, Piepoli A, Catalano D, Licciulli F, Carella M, Liuni S, Pesole
G, Perri F, Ancona N. Statistical assessment of functional categories of genes
deregulated in pathological conditions by using microarray data. Bioinformatics.
2007 Aug 15;23(16):2063-72. doi: 10.1093/bioinformatics/btm289. Epub 2007 May
31. PMID: 17540679.
88: Perri F, Cotugno R, Piepoli A, Merla A, Quitadamo M, Gentile A, Pilotto A,
Annese V, Andriulli A. Aberrant DNA methylation in non-neoplastic gastric mucosa
of H. Pylori infected patients and effect of eradication. Am J Gastroenterol.
2007 Jul;102(7):1361-71. doi: 10.1111/j.1572-0241.2007.01284.x. Epub 2007 May
17. PMID: 17509026.
89: Piepoli A, Schirru E, Mastrorilli A, Gentile A, Cotugno R, Quitadamo M,
Merla A, Congia M, Usai Satta P, Perri F. Genotyping of the lactase-phlorizin
hydrolase c/t-13910 polymorphism by means of a new rapid denaturing high-
performance liquid chromatography-based assay in healthy subjects and colorectal
cancer patients. J Biomol Screen. 2007 Aug;12(5):733-9. doi:
10.1177/1087057107301328. Epub 2007 May 3. PMID: 17478481.
90: Iacobellis A, Marcellini M, Andriulli A, Perri F, Leandro G, Devito R,
Nobili V. Non invasive evaluation of liver fibrosis in paediatric patients with
nonalcoholic steatohepatitis. World J Gastroenterol. 2006 Dec 28;12(48):7821-5.
doi: 10.3748/wjg.v12.i48.7821. PMID: 17203527; PMCID: PMC4087549.
91: Iacobellis A, Siciliano M, Perri F, Annicchiarico BE, Leandro G, Caruso N,
Accadia L, Bombardieri G, Andriulli A. Peginterferon alfa-2b and ribavirin in
patients with hepatitis C virus and decompensated cirrhosis: a controlled study.
J Hepatol. 2007 Feb;46(2):206-12. doi: 10.1016/j.jhep.2006.08.020. Epub 2006 Oct
20. PMID: 17125876.
92: Piepoli A, Gentile A, Valvano MR, Barana D, Oliani C, Cotugno R, Quitadamo
M, Andriulli A, Perri F. Lack of association between UGT1A7, UGT1A9, ARP, SPINK1
and CFTR gene polymorphisms and pancreatic cancer in Italian patients. World J
Gastroenterol. 2006 Oct 21;12(39):6343-8. doi: 10.3748/wjg.v12.i39.6343. PMID:
17072959; PMCID: PMC4088144.
93: Pilotto A, Franceschi M, Leandro G, Scarcelli C, D'Ambrosio LP, Seripa D,
Perri F, Niro V, Paris F, Andriulli A, Di Mario F. Clinical features of reflux
esophagitis in older people: a study of 840 consecutive patients. J Am Geriatr
Soc. 2006 Oct;54(10):1537-42. doi: 10.1111/j.1532-5415.2006.00899.x. PMID:
17038071.
94: Niro GA, Ciancio A, Gaeta GB, Smedile A, Marrone A, Olivero A, Stanzione M,
David E, Brancaccio G, Fontana R, Perri F, Andriulli A, Rizzetto M. Pegylated
interferon alpha-2b as monotherapy or in combination with ribavirin in chronic
hepatitis delta. Hepatology. 2006 Sep;44(3):713-20. doi: 10.1002/hep.21296.
PMID: 16941685.
95: Maglietta R, D'Addabbo A, Piepoli A, Perri F, Liuni S, Pesole G, Ancona N.
Selection of relevant genes in cancer diagnosis based on their prediction
accuracy. Artif Intell Med. 2007 May;40(1):29-44. doi:
10.1016/j.artmed.2006.06.002. Epub 2006 Aug 22. PMID: 16920342.
96: Ancona N, Maglietta R, Piepoli A, D'Addabbo A, Cotugno R, Savino M, Liuni S,
Carella M, Pesole G, Perri F. On the statistical assessment of classifiers using
DNA microarray data. BMC Bioinformatics. 2006 Aug 19;7:387. doi:
10.1186/1471-2105-7-387. PMID: 16919171; PMCID: PMC1564153.
97: Andriulli A, De Sio I, Brunello F, Salmi A, Solmi L, Facciorusso D,
Caturelli E, Perri F. Survival of patients with early hepatocellular carcinoma
treated by percutaneous alcohol injection. Aliment Pharmacol Ther. 2006 May
1;23(9):1329-35. doi: 10.1111/j.1365-2036.2006.02901.x. PMID: 16629938.
98: Pilotto A, Perri F, Leandro G, Franceschi M; Aging and Acid-Related Disease
Study Group. Effect of Helicobacter pylori eradication on the outcome of reflux
esophagitis and chronic gastritis in the elderly. A randomized, multicenter,
eight-month study. Gerontology. 2006;52(2):99-106. doi: 10.1159/000090955. PMID:
16508317.
99: Giacobbe A, Facciorusso D, Modola G, Caturelli E, Caruso N, Perri F, Tardio
B, Bisceglia M, Andriulli A. Splenic abscess secondary to penetrating gastric
ulcer. Minerva Gastroenterol Dietol. 1998 Jun;44(2):111-5. PMID: 16495891.
100: Perri F, Pastore MR, Annese V. 13C-octanoic acid breath test for measuring
gastric emptying of solids. Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5 Suppl
1):3-8. PMID: 16457123.
101: Perri F, Quitadamo M, Ricciardi R, Piepoli A, Cotugno R, Gentile A, Pilotto
A, Andriulli A. Comparison of a monoclonal antigen stool test (Hp StAR) with the
13C-urea breath test in monitoring Helicobacter pylori eradication therapy.
World J Gastroenterol. 2005 Oct 7;11(37):5878-81. doi: 10.3748/wjg.v11.i37.5878.
PMID: 16270402; PMCID: PMC4479693.
102: Niro GA, Ciancio A, Tillman HL, Lagget M, Olivero A, Perri F, Fontana R,
Little N, Campbell F, Smedile A, Manns MP, Andriulli A, Rizzetto M. Lamivudine
therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot
study. Aliment Pharmacol Ther. 2005 Aug 1;22(3):227-32. doi:
10.1111/j.1365-2036.2005.02542.x. PMID: 16091060.
103: Perri F, Piepoli A, Bonvicini C, Gentile A, Quitadamo M, Di Candia M,
Cotugno R, Cattaneo F, Zagari MR, Ricciardiello L, Gennarelli M, Bazzoli F,
Ranzani GN, Andriulli A. Cytokine gene polymorphisms in gastric cancer patients
from two Italian areas at high and low cancer prevalence. Cytokine. 2005 Jun
7;30(5):293-302. doi: 10.1016/j.cyto.2005.01.011. Epub 2005 Apr 2. PMID:
15927855.
104: Manes G, Pieramico O, Perri F, Vaira D, Giardullo N, Romano M, Nardone G,
Balzano A. Twice-daily standard dose of omeprazole achieves the necessary level
of acid inhibition for Helicobacter pylori eradication. A randomized controlled
trial using standard and double doses of omeprazole in triple therapy. Dig Dis
Sci. 2005 Mar;50(3):443-8. doi: 10.1007/s10620-005-2455-6. PMID: 15810623.
105: Annese V, Piepoli A, Latiano A, Lombardi G, Napolitano G, Caruso N,
Cocchiara E, Accadia L, Perri F, Andriulli A. HLA-DRB1 alleles may influence
disease phenotype in patients with inflammatory bowel disease: a critical
reappraisal with review of the literature. Dis Colon Rectum. 2005
Jan;48(1):57-64; discussion 64-5. doi: 10.1007/s10350-004-0747-0. PMID:
15690658.
106: Annese V, Lombardi G, Perri F, D'Incà R, Ardizzone S, Riegler G, Giaccari
S, Vecchi M, Castiglione F, Gionchetti P, Cocchiara E, Vigneri S, Latiano A,
Palmieri O, Andriulli A. Variants of CARD15 are associated with an aggressive
clinical course of Crohn's disease--an IG-IBD study. Am J Gastroenterol. 2005
Jan;100(1):84-92. doi: 10.1111/j.1572-0241.2005.40705.x. PMID: 15654786.
107: Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G,
Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A. Anti-
Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease:
comparison of different assays and correlation with clinical features. Aliment
Pharmacol Ther. 2004 Nov 15;20(10):1143-52. doi:
10.1111/j.1365-2036.2004.02258.x. PMID: 15569117.
108: Pilotto A, Franceschi M, Longoa MG, Scarcelli C, Orsitto G, Perri FC,
D'Ambrosio LP, Leandro G. Helicobacter pylori infection and the prevention of
peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose
aspirin. Dig Liver Dis. 2004 Oct;36(10):666-70. doi: 10.1016/j.dld.2004.05.011.
PMID: 15506665.
109: Andriulli A, de Sio I, Solmi L, De Carlis L, Troisi R, Grasso A, Festa V,
Caturelli E, Giacomoni A, Del Vecchio Blanco C, De Hemptinne B, Burroughs A,
Perri F. Survival of cirrhotic patients with early hepatocellular carcinoma
treated by percutaneous ethanol injection or liver transplantation. Liver
Transpl. 2004 Nov;10(11):1355-63. doi: 10.1002/lt.20251. PMID: 15497162.
110: Andriulli A, Solmi L, Loperfido S, Leo P, Festa V, Belmonte A, Spirito F,
Silla M, Forte G, Terruzzi V, Marenco G, Ciliberto E, Sabatino A, Monica F,
Magnolia MR, Perri F. Prophylaxis of ERCP-related pancreatitis: a randomized,
controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol
Hepatol. 2004 Aug;2(8):713-8. doi: 10.1016/s1542-3565(04)00295-2. PMID:
15290665.
111: Pilotto A, Franceschi M, Leandro G, Longo MG, Perri F, Scarcelli C.
Helicobacter pylori infection and the risk of gastro-duodenal damage in
symptomatic elderly chronic low-dose aspirin users: effect of antisecretory
drugs. Age Ageing. 2004 Jul;33(4):402-4. doi: 10.1093/ageing/afh099. PMID:
15226108.
112: Perri F, Marras RM, Ricciardi R, Quitadamo M, Andriulli A. 13C-breath tests
in hepatology (cytosolic liver function). Eur Rev Med Pharmacol Sci. 2004 Jan-
Feb;8(1):47-9. PMID: 15209154.
113: Perri F. Reply to Jonderko et al. The reproducibility of 13CO2 measurement.
19: 142-4. Aliment Pharmacol Ther. 2004 Feb 1;19(3):376-8. doi:
10.1111/j.0269-2813.2004.01815.x. PMID: 14984386.
114: Perri F, Qasim A, Marras L, O'Morain C. Treatment of Helicobacter pylori
infection. Helicobacter. 2003;8 Suppl 1:53-60. doi:
10.1046/j.1523-5378.2003.00162.x. PMID: 14617218.
115: Niro GA, Santantonio T, Fontana R, Insalata M, Facciorusso D, Signorile F,
Perri F, Guastadisegni A, Gioffreda D, Palmieri O, Pastore G, Andriulli A. Re-
treatment of patients with anti-HBe-positive chronic hepatitis B who relapsed
after an initial course of lamivudine. Aliment Pharmacol Ther. 2003 Nov
1;18(9):933-40. doi: 10.1046/j.1365-2036.2003.01787.x. PMID: 14616157.
116: Perri F, Festa V, Merla A, Barberani F, Pilotto A, Andriulli A. Randomized
study of different 'second-line' therapies for Helicobacter pylori infection
after failure of the standard 'Maastricht triple therapy'. Aliment Pharmacol
Ther. 2003 Oct 15;18(8):815-20. doi: 10.1046/j.1365-2036.2003.01755.x. PMID:
14535875.
117: Perri F, Piepoli A, Stanziale P, Merla A, Zelante L, Andriulli A. Mutation
analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene,
the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal
type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis. Eur J Hum
Genet. 2003 Sep;11(9):687-92. doi: 10.1038/sj.ejhg.5201035. PMID: 12939655.
118: Andriulli A, Grossi E, Buscema M, Festa V, Intraligi NM, Dominici P,
Cerutti R, Perri F; NUD LOOK Study Group. Contribution of artificial neural
networks to the classification and treatment of patients with uninvestigated
dyspepsia. Dig Liver Dis. 2003 Apr;35(4):222-31. doi:
10.1016/s1590-8658(03)00057-4. PMID: 12801032.
119: Perri F, Festa V, Grossi E, Garbagna N, Leandro G, Andriulli A; "NUD-LOOK"
Study Group. Dyspepsia and Helicobacter pylori infection: a prospective
multicentre observational study. Dig Liver Dis. 2003 Mar;35(3):157-64. doi:
10.1016/s1590-8658(03)00023-9. PMID: 12779069.
120: Perri F, Zagari RM, Uebersax JS, Quitadamo M, Bazzoli F; Helicobacter
Pylori Sige Study Group on ¹³CO₂ Measurement Standardization; Amarri S, Armuzzi
A, Cantoni F, Colombo R, De Berardinis F, De Pretis G, Dell'Anna L, Festi D,
Neri M, Geypens B, Ierardi E, Johnson P, Marchi S, Masoero G, Micunco C, Palli
D, Russo A, Palmas F, Realdi G, Sangaletti O, Savarino V, Stellaard F, Vigneri
S. An inter- and intra-laboratory comparison of breath ¹³CO₂analysis. Aliment
Pharmacol Ther. 2003 May 15;17(10):1291-7. doi:
10.1046/j.1365-2036.2003.01584.x. PMID: 12755842.
121: Perri F. Helicobacter pylori infection: the diagnostic dilemma is still
going on! Dig Liver Dis. 2003 Feb;35(2):71-2. doi:
10.1016/s1590-8658(03)00013-6. PMID: 12747622.
122: Zullo A, Vaira D, Vakil N, Hassan C, Gatta L, Ricci C, De Francesco V,
Menegatti M, Tampieri A, Perna F, Rinaldi V, Perri F, Papadìa C, Fornari F,
Pilati S, Mete LS, Merla A, Potì R, Marinone G, Savioli A, Campo SM, Faleo D,
Ierardi E, Miglioli M, Morini S. High eradication rates of Helicobacter pylori
with a new sequential treatment. Aliment Pharmacol Ther. 2003 Mar
1;17(5):719-26. doi: 10.1046/j.1365-2036.2003.01461.x. Erratum in: Aliment
Pharmacol Ther. 2003 May 1;17(9):1205. PMID: 12641522.
123: Perri F, Piepoli A, Andriulli A. On the role of CFTR, PSSR1 and PST1/SPINK1
in idiopathic chronic pancreatitis. Eur J Hum Genet. 2003 Feb;11(2):107; author
reply 108. doi: 10.1038/sj.ejhg.5200944. PMID: 12634855.
124: Perri F, Manes G, Neri M, Vaira D, Nardone G. Helicobacter pylori antigen
stool test and 13C-urea breath test in patients after eradication treatments. Am
J Gastroenterol. 2002 Nov;97(11):2756-62. doi: 10.1111/j.1572-0241.2002.07065.x.
PMID: 12425544.
125: Andriulli A, Clemente R, Solmi L, Terruzzi V, Suriani R, Sigillito A,
Leandro G, Leo P, De Maio G, Perri F. Gabexate or somatostatin administration
before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter,
placebo-controlled, randomized clinical trial. Gastrointest Endosc. 2002
Oct;56(4):488-95. doi: 10.1067/mge.2002.128130. PMID: 12297762.
126: Perri F, Ricciardi R, Merla A, Piepoli A, Gasperi V, Quitadamo M, Andriulli
A. Appropriateness of urea breath test: a prospective observational study based
on Maastricht 2000 guidelines. Aliment Pharmacol Ther. 2002 Aug;16(8):1443-7.
doi: 10.1046/j.1365-2036.2002.01315.x. PMID: 12182743.
127: Perri F, Piepoli A, Quitadamo M, Quarticelli M, Merla A, Bisceglia M. HLA-
DQA1 and -DQB1 genes and Helicobacter pylori infection in Italian patients with
gastric adenocarcinoma. Tissue Antigens. 2002 Jan;59(1):55-7. doi:
10.1034/j.1399-0039.2002.590112.x. PMID: 11972882.
128: Perri F, Festa V, Merla A, Quitadamo M, Clemente R, Andriulli A.
Amoxicillin/tetracycline combinations are inadequate as alternative therapies
for Helicobacter pylori infection. Helicobacter. 2002 Apr;7(2):99-104. doi:
10.1046/j.1083-4389.2002.00066.x. PMID: 11966868.
129: Perri F, Villani MR, Festa V, Quitadamo M, Andriulli A. Predictors of
failure of Helicobacter pylori eradication with the standard 'Maastricht triple
therapy'. Aliment Pharmacol Ther. 2001 Jul;15(7):1023-9. doi:
10.1046/j.1365-2036.2001.01006.x. PMID: 11421878.
130: Perri F, Villani MR, Quitadamo M, Annese V, Niro GA, Andriulli A.
Ranitidine bismuth citrate-based triple therapies after failure of the standard
'Maastricht triple therapy': a promising alternative to the quadruple therapy?
Aliment Pharmacol Ther. 2001 Jul;15(7):1017-22. doi:
10.1046/j.1365-2036.2001.01002.x. PMID: 11421877.
131: Perri F, Bisceglia M, Giannatempo GM, Andriulli A. Cerebellar metastasis as
a unique presenting feature of gastric cancer. J Clin Gastroenterol. 2001
Jul;33(1):80-1. doi: 10.1097/00004836-200107000-00021. PMID: 11418800.
132: Perri F. Diagnosis of Helicobacter pylori infection: which is the best
test? The urea breath test. Dig Liver Dis. 2000 Dec;32 Suppl 3:S196-8. doi:
10.1016/s1590-8658(00)80277-7. PMID: 11245294.
133: Perri F, Festa V, Clemente R, Villani MR, Quitadamo M, Caruso N, Bergoli
ML, Andriulli A. Randomized study of two "rescue" therapies for Helicobacter
pylori-infected patients after failure of standard triple therapies. Am J
Gastroenterol. 2001 Jan;96(1):58-62. doi: 10.1111/j.1572-0241.2001.03452.x.
PMID: 11197288.
134: Luzza F, Imeneo M, Marasco A, Crotta S, Ierardi E, Usai P, Virgilio C,
Nardone G, Marchi S, Sanna G, Perri F, Maurizio Zagari R, Bazzoli F. Evaluation
of a commercial serological kit for detection of salivary immunoglobulin G to
Helicobacter pylori: a multicentre study. Eur J Gastroenterol Hepatol. 2000
Oct;12(10):1117-20. doi: 10.1097/00042737-200012100-00008. PMID: 11057457.
135: Iaquinto G, Todisco A, Giardullo N, D'Onofrio V, Pasquale L, De Luca A,
Andriulli A, Perri F, Rega C, De Chiara G, Landi M, Taccone W, Leandro G, Figura
N. Antibody response to Helicobacter pylori CagA and heat-shock proteins in
determining the risk of gastric cancer development. Dig Liver Dis. 2000 Jun-
Jul;32(5):378-83. doi: 10.1016/s1590-8658(00)80256-x. PMID: 11030181.
136: Perri F, Pastore M, Zicolella A, Annese V, Quitadamo M, Andriulli A.
Gastric emptying of solids is delayed in celiac disease and normalizes after
gluten withdrawal. Acta Paediatr. 2000 Aug;89(8):921-5. doi:
10.1080/080352500750043341. PMID: 10976830.
137: Lombardi G, Annese V, Piepoli A, Bovio P, Latiano A, Napolitano G, Perri F,
Conoscitore P, Andriulli A. Antineutrophil cytoplasmic antibodies in
inflammatory bowel disease: clinical role and review of the literature. Dis
Colon Rectum. 2000 Jul;43(7):999-1007. doi: 10.1007/BF02237367. PMID: 10910250.
138: Perri F, Festa V, Clemente R, Quitadamo M, Andriulli A. Rifabutin-based
'rescue therapy' for Helicobacter pylori infected patients after failure of
standard regimens. Aliment Pharmacol Ther. 2000 Mar;14(3):311-6. doi:
10.1046/j.1365-2036.2000.00719.x. PMID: 10735924.
139: Perri F, Andriulli A. Absence of benefit of eradicating Helicobacter pylori
in patients with nonulcer dyspepsia. N Engl J Med. 2000 Feb 24;342(8):589-90.
PMID: 10691507.
140: Delbende B, Perri F, Couturier O, Leodolter A, Mauger P, Bridgi B, Bizais
Y, des Varannes SB, Andriulli A, Galmiche JP. 13C-octanoic acid breath test for
gastric emptying measurement. Eur J Gastroenterol Hepatol. 2000 Jan;12(1):85-91.
doi: 10.1097/00042737-200012010-00016. PMID: 10656216.
141: Perri F, Clemente R, Festa V, De Ambrosio CC, Quitadamo M, Fusillo M,
Grossi E, Andriulli A. Serum tumour necrosis factor-alpha is increased in
patients with Helicobacter pylori infection and CagA antibodies. Ital J
Gastroenterol Hepatol. 1999 May;31(4):290-4. PMID: 10425573.
142: Perri F, Andriulli A. "Mixed" triglyceride breath test: methodological
problems and clinical applications. Rev Med Univ Navarra. 1998 Apr-
Jun;42(2):99-103. PMID: 10420946.
143: Andrulli A, Perri F, Annese V. Guidelines for treatment of acute
pancreatitis. Gut. 1999 Apr;44(4):579-80. doi: 10.1136/gut.44.4.579a. PMID:
10366292; PMCID: PMC1727445.
144: Niro GA, Casey JL, Gravinese E, Garrubba M, Conoscitore P, Sagnelli E,
Durazzo M, Caporaso N, Perri F, Leandro G, Facciorusso D, Rizzetto M, Andriulli
A. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J
Hepatol. 1999 Apr;30(4):564-9. doi: 10.1016/s0168-8278(99)80185-8. PMID:
10207796.
145: Galmiche JP, Delbende B, Perri F, Andriulli A. 13C octanoic acid breath
test. Gut. 1998 Nov;43 Suppl 3(Suppl 3):S28-30. doi: 10.1136/gut.43.2008.s28.
PMID: 10083872; PMCID: PMC1766640.
146: Perri F, Festa V, Clemente R, Quitadamo M, Andriulli A. Methodological
problems and pitfalls of urea breath test. Ital J Gastroenterol Hepatol. 1998
Oct;30 Suppl 3:S315-9. PMID: 10077764.
147: Florio F, Nardella M, Balzano S, Giacobbe A, Perri F. Congenital
intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol. 1998 Sep-
Oct;21(5):421-4. doi: 10.1007/s002709900291. PMID: 9853150.
148: Perri F, Clemente R, Festa V, Quitadamo M, Andriulli A. Pancreatic exocrine
function tests. Scand J Gastroenterol. 1998 Oct;33(10):1118-20. doi:
10.1080/003655298750026859. PMID: 9829370.
149: Perri F, Clemente R, Festa V, Annese V, Quitadamo M, Rutgeerts P, Andriulli
A. Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori
infection and delayed gastric emptying. Am J Gastroenterol. 1998
Nov;93(11):2082-8. doi: 10.1111/j.1572-0241.1998.00597.x. PMID: 9820377.
150: Perri F, Pastore M, Festa V, Clemente R, Quitadamo M, D'Altilia MR, Niro G,
Paolucci P, Andriulli A. Intraduodenal lipase activity in celiac disease
assessed by means of 13C mixed-triglyceride breath test. J Pediatr Gastroenterol
Nutr. 1998 Oct;27(4):407-10. doi: 10.1097/00005176-199810000-00008. PMID:
9779968.
151: Perri F, Pastore M, Clemente R, Festa V, Quitadamo M, Niro G, Conoscitore
P, Rutgeerts P, Andriulli A. Helicobacter pylori infection may undergo
spontaneous eradication in children: a 2-year follow-up study. J Pediatr
Gastroenterol Nutr. 1998 Aug;27(2):181-3. doi: 10.1097/00005176-199808000-00010.
PMID: 9702650.
152: Perri F, Clemente R, Festa V, Quitadamo M, Niro G, Andriulli A.
13C-octanoic acid breath test: a reliable tool for measuring gastric emptying.
Ital J Gastroenterol Hepatol. 1998 Apr;30(2):211-7. PMID: 9675662.
153: Perri F, Clemente R, Festa V, Quitadamo M, Conoscitore P, Niro G, Ghoos Y,
Rutgeerts P, Andriulli A. Relationship between the results of pre-treatment urea
breath test and efficacy of eradication of Helicobacter pylori infection. Ital J
Gastroenterol Hepatol. 1998 Apr;30(2):146-50. PMID: 9675647.
154: Perri F, Festa V, Andriulli A. Treatment of antibiotic-resistant
Helicobacter pylori. N Engl J Med. 1998 Jul 2;339(1):53. doi:
10.1056/NEJM199807023390116. PMID: 9660694.
155: Perri F, Annese V, Piepoli A, Napolitano G, Lombardi G, Ciavarella G, Di
Giorgio G, Andriulli A. HLA antigens and pANCA define ulcerative colitis as a
genetically heterogeneous disorder. Ital J Gastroenterol Hepatol. 1998
Feb;30(1):56-61. PMID: 9615268.
156: Andriulli A, Leandro G, Clemente R, Festa V, Caruso N, Annese V, Lezzi G,
Lichino E, Bruno F, Perri F. Meta-analysis of somatostatin, octreotide and
gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther.
1998 Mar;12(3):237-45. doi: 10.1046/j.1365-2036.1998.00295.x. PMID: 9570258.
157: Greco L, Corazza G, Babron MC, Clot F, Fulchignoni-Lataud MC, Percopo S,
Zavattari P, Bouguerra F, Dib C, Tosi R, Troncone R, Ventura A, Mantavoni W,
Magazzù G, Gatti R, Lazzari R, Giunta A, Perri F, Iacono G, Cardi E, de
Virgiliis S, Cataldo F, De Angelis G, Musumeci S, Clerget-Darpoux F, et al.
Genome search in celiac disease. Am J Hum Genet. 1998 Mar;62(3):669-75. doi:
10.1086/301754. PMID: 9497251; PMCID: PMC1376948.
158: Perri F, Clemente R, Festa V, Andriulli A. 13C-Octanoic acid breath test:
valueless test for gastric emptying? Gastroenterology. 1998 Apr;114(4):857-9.
doi: 10.1016/s0016-5085(98)70609-2. PMID: 9547108.
159: Perri F, Clemente R, Pastore M, Quitadamo M, Festa V, Bisceglia M, Li
Bergoli M, Lauriola G, Leandro G, Ghoos Y, Rutgeerts P, Andriulli A. The
13C-urea breath test as a predictor of intragastric bacterial load and severity
of Helicobacter pylori gastritis. Scand J Clin Lab Invest. 1998 Feb;58(1):19-27.
doi: 10.1080/00365519850186797. PMID: 9516653.
160: Perri F, Festa V, Clemente R, Andriulli A. Bacterial density of
Helicobacter pylori predicts the success of triple therapy in bleeding duodenal
ulcer. Gastrointest Endosc. 1997 Sep;46(3):287. doi:
10.1016/s0016-5107(97)70107-x. PMID: 9378226.
161: Perri F, Pastore M, Leandro G, Clemente R, Ghoos Y, Peeters M, Annese V,
Quitadamo M, Latiano A, Rutgeerts P, Andriulli A. Helicobacter pylori infection
and growth delay in older children. Arch Dis Child. 1997 Jul;77(1):46-9. doi:
10.1136/adc.77.1.46. PMID: 9279151; PMCID: PMC1717226.
162: Klein PD, Logan RP, Amarri S, Andriulli A, Iaquinto G, Luzza F, Pajarès
Garcia JM, Pazzi P, Perri F, Pozzato P, Roda A, Vaira D, Zagari RM. Update on
Helicobacter pylori research. Diagnosis. Eur J Gastroenterol Hepatol. 1997
Jun;9(6):617-8. PMID: 9222737.
163: Strocchi A, Corazza GR, Anania C, Benati G, Malservisi S, Cherchi MV, Certo
M, Malorgio E, Marano M, Mazzeo V, Ginaldi L, Giorgetti GM, Pimpo T, Sciarretta
G, Ventrucci M, Quondamcarlo C, Pelli MA, Perri F. Quality control study of H2
breath testing for the diagnosis of carbohydrate malabsorption in Italy. The
"Tenue Club" Group. Ital J Gastroenterol Hepatol. 1997 Apr;29(2):122-7. PMID:
9646191.
164: Annese V, Basciani M, Perri F, Lombardi G, Frusciante V, Simone P,
Andriulli A, Vantrappen G. Controlled trial of botulinum toxin injection versus
placebo and pneumatic dilation in achalasia. Gastroenterology. 1996
Dec;111(6):1418-24. doi: 10.1016/s0016-5085(96)70002-1. PMID: 8942719.
165: Annese V, Basciani M, Lombardi G, Caruso N, Perri F, Simone P, Andriulli A.
Perendoscopic injection of botulinum toxin is effective in achalasia after
failure of myotomy or pneumatic dilation. Gastrointest Endosc. 1996
Oct;44(4):461-5. doi: 10.1016/s0016-5107(96)70100-1. PMID: 8905369.
166: Perri F, Annese V, Napolitano G, Caruso N, Clemente R, Villani MR,
Andriulli A. Subgroups of patients with Crohn's disease have different clinical
outcomes. Inflamm Bowel Dis. 1996 Spring;2(1):1-5. PMID: 23282449.
167: Perri F, Annese V, Pastore M, Andriulli A. Microscopic colitis progressed
to collagenous colitis: a morphometric study. Ital J Gastroenterol. 1996
Apr;28(3):147-51. PMID: 8789825.
168: Perri F, Ghoos YF, Maes BD, Geypens BJ, Ectors N, Geboes K, Hiele MI,
Rutgeerts PJ. Gastric emptying and Helicobacter pylori infection in duodenal
ulcer disease. Dig Dis Sci. 1996 Mar;41(3):462-8. doi: 10.1007/BF02282319. PMID:
8617116.
169: Perri F, Maes B, Geypens B, Ghoos Y, Hiele M, Rutgeerts P. The influence of
isolated doses of drugs, feeding and colonic bacterial ureolysis on urea breath
test results. Aliment Pharmacol Ther. 1995 Dec;9(6):705-9. doi:
10.1111/j.1365-2036.1995.tb00442.x. PMID: 8824660.
170: Annese V, Napolitano G, Minervini MM, Perri F, Ciavarella G, Di Giorgio G,
Andriulli A. Family occurrence of achalasia. J Clin Gastroenterol. 1995
Jun;20(4):329-30. doi: 10.1097/00004836-199506000-00016. PMID: 7665825.
171: Perri F, Iuliano R, Valente G, Angelillo IF, Arrigoni A, Campra D, Recchia
S, Andriulli A. Minute and small early gastric cancers in a Western population:
a clinicopathologic study. Gastrointest Endosc. 1995 May;41(5):475-80. doi:
10.1016/s0016-5107(05)80006-9. PMID: 7615226.
172: Perri F, Ghoos Y, Hiele M, Andriulli A, Rutgeerts P. The urea breath test:
a non-invasive clinical tool for detecting Helicobacter pylori infection. Ital J
Gastroenterol. 1995 Mar;27(2):55-63. PMID: 7579592.
173: Perri F, Pastore M, Andriulli A. Aminopyrine breath test. Dig Dis Sci. 1994
Nov;39(11):2445-7. doi: 10.1007/BF02087664. PMID: 7956614.
174: Perri F, Pastore M, Annese V, Caruso N, Napolitano G, Andriulli A.
Manifestazioni osteoarticolari in corso di malattie epatiche e gastrointestinali
[Osteoarticular manifestations during liver and gastrointestinal diseases].
Minerva Gastroenterol Dietol. 1994 Sep;40(3):137-50. Italian. PMID: 7948323.
175: Perri F, Pastore M, Annese V, Andriulli A. The aminopyrine breath test.
Ital J Gastroenterol. 1994 Jul-Aug;26(6):306-17. PMID: 7949268.
176: Caturelli E, Pompili M, Squillante MM, Sperandeo G, Carughi S, Sperandeo M,
Perri F, Andriulli A, Cellerino C, Rapaccini GL. Cruveilhier-Baumgarten
syndrome: an efficient spontaneous portosystemic collateral preventing
oesophageal varices bleeding. J Gastroenterol Hepatol. 1994 May-Jun;9(3):236-41.
doi: 10.1111/j.1440-1746.1994.tb01716.x. PMID: 8054522.
177: Annese V, Napolitano G, Caruso N, Perri F, Conoscitore P, Frusciante V,
Barbano F, Andriulli A. Segmental motor abnormalities of the distal oesophagus.
Ital J Gastroenterol. 1994 May;26(4):179-83. PMID: 7949261.
178: Perri F, Annese V, Federici T, Napolitano G, Nardella G, Caturelli E,
Andriulli A. Benign duodenocolic fistula: an unusual case of gastrointestinal
bleeding. Gastrointest Endosc. 1993 Nov-Dec;39(6):827-30. doi:
10.1016/s0016-5107(93)70279-5. PMID: 8293914.
179: Manna R, Perri F, Ghirlanda G, Zeppilli P, Carughi S, Annese V, Uccioli L,
Mango G. Association of ankylosing spondylitis with hairy cell leukemia: a
previously once reported case. Z Rheumatol. 1985 Mar-Apr;44(2):93-6. PMID:
4050146.
180: Ghirlanda G, Perri F, Manna R, Uccioli L. Association of ankylosing
spondylitis and monoclonal gammopathy: clinical case report and pathogenetic
considerations. Z Rheumatol. 1984 Jan-Feb;43(1):42-5. PMID: 6424353.
181: Ghirlanda G, Perri F, Uccioli L, Greco AV. Epidermal growth factor (EGF).
Attività biologica e significato fisiopatologico [Epidermal growth factor (EGF).
Biological activity and physiopathological significance]. Recenti Prog Med. 1983
Nov;74(11):1311-26. Italian. PMID: 6324305.
182: Ghirlanda G, Uccioli L, Perri F, Altomonte L, Bertoli A, Manna R, Frati L,
Greco AV. Epidermal growth factor, somatostatin, and psoriasis. Lancet. 1983 Jan
1;1(8314-5):65. doi: 10.1016/s0140-6736(83)91594-5. PMID: 6129392